-
1
-
-
84862584058
-
Whole-genome analysis informs breast cancer response to aromatase inhibition
-
Ellis MJ, Ding L, Shen D, et al. Whole-genome analysis informs breast cancer response to aromatase inhibition. Nature. 2012;486: 353-60.
-
(2012)
Nature
, vol.486
, pp. 353-360
-
-
Ellis, M.J.1
Ding, L.2
Shen, D.3
-
2
-
-
33846965616
-
Prognostic value of Ki67 expression after short-term presurgical endocrine therapy for primary breast cancer
-
Dowsett M, Smith IE, Ebbs SR, et al. Prognostic value of Ki67 expression after short-term presurgical endocrine therapy for primary breast cancer. J Natl Cancer Inst. 2007;99:167-70.
-
(2007)
J Natl Cancer Inst.
, vol.99
, pp. 167-170
-
-
Dowsett, M.1
Smith, I.E.2
Ebbs, S.R.3
-
3
-
-
64949102825
-
Improved surgical outcomes for breast cancer patients receiving neoadjuvant aromatase inhibitor therapy: Results from a multicenter phase II trial
-
discussion 915-16
-
Olson JA, Jr., Budd GT, Carey LA, et al. Improved surgical outcomes for breast cancer patients receiving neoadjuvant aromatase inhibitor therapy: results from a multicenter phase II trial. J Am Coll Surg. 2009;208:906-14; discussion 915-16.
-
(2009)
J Am Coll Surg.
, vol.208
, pp. 906-914
-
-
Olson Jr., J.A.1
Budd, G.T.2
Carey, L.A.3
-
4
-
-
19944429855
-
Short-term changes in Ki-67 during neoadjuvant treatment of primary breast cancer with anastrozole or tamoxifen alone or combined correlate with recurrence-free survival
-
Dowsett M, Smith IE, Ebbs SR, et al. Short-term changes in Ki-67 during neoadjuvant treatment of primary breast cancer with anastrozole or tamoxifen alone or combined correlate with recurrence-free survival. Clin Cancer Res. 2005;11:951s-8s.
-
(2005)
Clin Cancer Res.
, vol.11
-
-
Dowsett, M.1
Smith, I.E.2
Ebbs, S.R.3
-
5
-
-
53249154813
-
Outcome prediction for estrogen receptor-positive breast cancer based on postneoadjuvant endocrine therapy tumor characteristics
-
Ellis MJ, Tao Y, Luo J, et al. Outcome prediction for estrogen receptor-positive breast cancer based on postneoadjuvant endocrine therapy tumor characteristics. J Natl Cancer Inst. 2008;100:1380-8.
-
(2008)
J Natl Cancer Inst.
, vol.100
, pp. 1380-1388
-
-
Ellis, M.J.1
Tao, Y.2
Luo, J.3
-
6
-
-
78349309809
-
Tumor Ki67 proliferation index within 4 weeks of initiating neoadjuvant endocrine therapy for early identification of non-responders
-
abstr 78
-
Ellis MJ, Luo J, Tao Y, et al. Tumor Ki67 proliferation index within 4 weeks of initiating neoadjuvant endocrine therapy for early identification of non-responders. Cancer Res. 2009;69(24 Suppl): abstr 78.
-
(2009)
Cancer Res.
, vol.69
, Issue.24 SUPPL.
-
-
Ellis, M.J.1
Luo, J.2
Tao, Y.3
-
7
-
-
79959268722
-
Randomized phase II neoadjuvant comparison between letrozole, anastrozole, and exemestane for postmenopausal women with estrogen receptor-rich stage 2 to 3 breast cancer: Clinical and biomarker outcomes and predictive value of the baseline PAM50-based intrinsic subtype--ACOSOG Z1031
-
Ellis MJ, Suman VJ, Hoog J, et al. Randomized phase II neoadjuvant comparison between letrozole, anastrozole, and exemestane for postmenopausal women with estrogen receptor-rich stage 2 to 3 breast cancer: clinical and biomarker outcomes and predictive value of the baseline PAM50-based intrinsic subtype--ACOSOG Z1031. J Clin Oncol. 2011;29:2342-9.
-
(2011)
J Clin Oncol.
, vol.29
, pp. 2342-2349
-
-
Ellis, M.J.1
Suman, V.J.2
Hoog, J.3
-
8
-
-
79958770468
-
Importance of PI3-kinase pathway in response/resistance to aromatase inhibitors
-
Ma CX, Crowder RJ, Ellis MJ. Importance of PI3-kinase pathway in response/resistance to aromatase inhibitors. Steroids. 2011;76:750-2.
-
(2011)
Steroids
, vol.76
, pp. 750-752
-
-
Ma, C.X.1
Crowder, R.J.2
Ellis, M.J.3
-
9
-
-
81555208345
-
Assessment of Ki67 in breast cancer: Recommendations from the International Ki67 Breast Working Goup
-
Dowsett M, Nielsen TO, A'Hern R, et al. Assessment of Ki67 in breast cancer: recommendations from the International Ki67 Breast Working Goup. J Natl Cancer Inst. 2011;103:1-9.
-
(2011)
J Natl Cancer Inst.
, vol.103
, pp. 1-9
-
-
Dowsett, M.1
Nielsen, T.O.2
A'Hern, R.3
|